Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 3

Review

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

       
Total article views   HTML views PDF downloads Totals
11,540 Dovepress* 11,540+ 5,104 16,644
Totals 11,540 5,104 16,644
*Since 26 March 2010
+Since July 2016

View citations on Google Scholar